Tuesday, December 13, 2016

Johnson & Johnson to Abandon Pursuit of Actelion

Johnson & Johnson has decided to pull out of talks to buy Swiss drug company Actelion Pharmaceuticals Ltd. after the price got too high, according to a person familiar with the matter.

from WSJ.com: US Business http://ift.tt/2hjFiLX
via IFTTT

No comments:

Post a Comment